Kolexia
Gaspar Nathalie
Pédiatrie
Gustave-Roussy
Villejuif, France
188 Activités
490 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Ostéosarcome Sarcome d'Ewing Tumeurs osseuses Récidive tumorale locale Tumeurs du poumon Métastase tumorale Tumeurs des tissus mous Nausée

Industries

Y-MABS THERAPEUTICS, INC.
2 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

SARCOME13: Multicentre, Randomised, Phase 2 Trial of Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients (Metastatic Osteosarcoma at Diagnosis or Localised Disease With Poor Histological Response)
Essai Clinique (Unicancer)   01 février 2024
OS2006 : Protocole de Traitement Des ostéosarcomes de l'Enfant, de l'Adolescent et de l'Adulte Comportant
Essai Clinique (Chugai)   09 janvier 2024
E7080-G000-231: An Open-Label, Multicenter Phase 2 Basket Study to Evaluate the Antitumor Activity and Safety of Lenvatinib in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Malignancies
Essai Clinique (Merck & Co.)   08 janvier 2024
ctDNA quantification improves estimation of outcomes in patients with high grade osteosarcoma: a translational study from the OS2006 trial.
Annals of oncology : official journal of the European Society for Medical Oncology   22 décembre 2023
European standard clinical practice recommendations for children and adolescents with primary and recurrent osteosarcoma
EJC paediatric oncology   01 décembre 2023
Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE).
ESMO open   13 novembre 2023
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.
British journal of cancer   01 novembre 2023
Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma: A Phase 2 Study of XL184 (Cabozantinib) in Treating Patients With Relapsed Osteosarcomas and Ewing Sarcomas
Essai Clinique (National Cancer Institute)   28 octobre 2023
Portrait de Nathalie Gaspar - pédiatre oncologue à l'Institut Gustave Roussy
Youtube @ Enfants Cancers Santé   23 octobre 2023
Chercheur du mois Découvrez le portrait de Nathalie Gaspar qui nous ...
Facebook   23 octobre 2023